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Abstract
Carboxylesterases (CEs) are a family of ubiquitous enzymes with broad substrate specificity, and
their inhibition may have important implications in pharmaceutical and agrochemical fields. One
of the most potent inhibitors both for mammalian and insect CEs are trifluoromethyl ketones
(TFMKs), but the mechanism of action of these chemicals is not completely understood. This
study examines the balance between reactivity versus steric effects in modulating the activity
against human carboxylesterase 1. The intrinsic reactivity of the ketone moiety is determined from
quantum mechanical computations, which combine gas phase B3LYP calculations with hydration
free energies estimated with the IEF/MST model. In addition, docking and molecular dynamics
simulations are used to explore the binding mode of the inhibitors along the deep gorge that
delineates the binding site. The results point out that the activity largely depends on the nature of
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the fluorinated ketone, since the activity is modulated by the balance between the intrinsic
electrophilicity of the carbonyl carbon atom and the ratio between keto and hydrate forms.
However, the results also suggest that the correct alignment of the alkyl chain in the binding site
can exert a large influence on the inhibitory activity, as this effect seems to override the intrinsic
reactivity features of the fluorinated ketone. Overall, the results sustain a subtle balance between
reactivity and steric effects in modulating the inhibitory activity of TFMK inhibitors.
Keywords
Fluorinated ketones; Esterase; Quantum mechanical computations; Molecular dynamics;
Structure-based drug design
Introduction
Carboxylesterases (CEs; EC 3.1.1.1) include a heterogeneous group of isozymes that
hydrolyze a wide range of aliphatic and aromatic esters, amides and thioesters [1,2]. They
comprise a multigene family that covers key hydrolytic enzymes with extremely broad
substrate specificity [3,4]. In addition, CEs are important in pest resistance since they
participate in detoxification processes of carbamate and organophosphate insecticides, and
insect strains resistant to these compounds have shown high levels of CEs [5,6]. Therefore,
the development of new CE inhibitors may lead to drugs with therapeutic and/or
agrochemical interest [7,8]. Esterases are important also in the degradation of a large variety
of insect pheromones and hormones, and thus are involved in many chemical and
biochemical processes.
An important group of chemicals that promote CE inhibition are fluorinated ketones, which
inhibit a variety of esterases such as acetylcholinesterase [9], juvenile hormone esterase
(JHE) [10] and human liver microsomal CEs [11,12], as well as enzymes such as
chymotrypsin and trypsin [13,14] and enzymes that metabolize chemical mediators
including fatty acid amide hydrolase and diacyl glycerol [15,16]. Trifluoromethyl ketones
(TFMKs) also reversibly inhibit pheromone-degrading esterases in male olfactory tissues
[17–19]. Therefore, these compounds represent a potential approach for the disruption of
pheromone communication as a new strategy for pest control [20,21]. Nevertheless, further
research is required to increase the clinical and agricultural application of these compounds
[22].
TFMKs behave as transition-state analogues, since the enzyme inhibition involves formation
of a tetrahedral adduct between the serine residue present at the active site and the highly
electrophilic carbonyl moiety [23,24]. Support for this mechanism of action comes from X-
ray crystallographic structures of the covalent complex of porcine pancreatic elastase and a
peptidyl α,α-difluoro-β-ketoamide [25], and of the JHE from the tobacco hornworm
Manduca sexta with 3-octyl-1,1,1-trifluoropropan-2-one [26]. Structure-activity relationship
studies indicate that the potency of TFMK inhibitors is modulated by lipophilicity, with the
optimal activity being associated with intermediate lipophilicity values (3<log P<5), molar
refractivity and the degree of fluorination [12,27]. These findings agree with the high
hydrophobicity of the gorge that leads to the catalytic site in CEs, and suggest a direct
influence of substituents attached to the ketone moiety on the chemical reactivity toward
formation of the tetrahedral adduct with the enzyme. The inhibitory potency has also been
related to the degree of ketone hydration [28], so that inhibitors that favor the tetrahedral
geometry of the hydrate (gem-diol) should stabilize the enzyme-inhibitor complex, thereby
resulting in more potent inhibitors. Finally, it has also been suggested that in β-
thiosubstituted TFMKs one of the hydroxyl groups in the gem-diol might form an
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intramolecular hydrogen bond with the sulfur atom, and that the strength of such hydrogen
bond shows a good correlation with the inhibitory potency of β-substituted TFMKs
involving several groups (O, S, SO and SO2) [29].
In order to gain further insight into the precise nature of the molecular determinants that
mediate the CE inhibitory activity of TFMKs, this work examines the contribution of both
reactivity and steric properties of a series of TFMK inhibitors. The activity of the
compounds has been determined experimentally against human carboxylesterase 1 (hCE1).
The reactivity properties of the fluorinated ketone moieties are examined by means of
density functional computations in conjunction with continuum solvation computations,
paying particular attention to the balance between keto and hydrate forms of the ketone
moiety. Moreover, the effect of the alkyl chain in TFMKs on the inhibitory potency is
investigated by combining docking calculations with molecular simulations. The results are
then used to discuss the relationship between the molecular structure of TFMKs and the
hCE1 inhibitory potency.
Methods
Chemicals
Compounds 1 and 5 were prepared as already reported by us [30,31], and the synthesis of
compounds 2 [12] and 3 [32] has been already described. Compounds 6 and 7 were obtained
from n-decanal and n-octanamide, respectively (manuscript in preparation). Difluoromethyl
ketone 8 was prepared as previously described [33] and 2-dodecanone (9) was commercially
available from Acros Organics (Geel, Belgium). Compound 10 was prepared by reaction of
the corresponding thiol with 4-chloro-1,1,1-trifluoro-2-butanone (manuscript in
preparation). Compounds 11–13 were taken from ref [28]. TFMKs 14, 16 and 17 were
prepared by trans-metallation reaction of the corresponding iododerivatives with tert-BuLi
followed by treatment with ethyl trifluoroacetate [31]. Compound 15 was synthesized from
1-octadecene with trifluoroacetaldehyde ethyl hemiacetal in the presence of a Lewis acid
followed by Dess-Martin oxidation [34] of the resulting trifluoromethyl carbinol (submitted
for publication). Finally, methylketone 18 was obtained by methyllithium addition to the
corresponding carboxylic acid [35].
Synthesis of 1,1,1-trifluoro-3-octyloxypropan-2-one (4)
BF3·Et2O (5.5 μL, 0.044 mmol) was slowly added to a stirred solution of 1-octanol (400 mg,
3.07 mmol) and 1,1,1-trifluoroepoxypropane (280 mg, 2.5 mmol) in CH2Cl2 (1 mL). The
reaction mixture was stirred at 40–45 °C for 16 h. The reaction mixture was partitioned
between CH2Cl2 (10 mL) and H2O (10 mL). The organic solution was washed with H2O (2
× 10 mL), dried (MgSO4), filtered and evaporated to afford a yellow oil, which was purified
by column chromatography on silica gel eluting with hexane:ether 9:1. The corresponding
trifluoromethyl carbinol (386 mg, 63%) was thus obtained as colorless oil. A 15% w/w
Dess-Martin reagent in CH2Cl2 (24 mL, 3.68 g, 1.05 mmol) was then added to a solution of
the carbinol (188 mg, 0.77 mmol) in CH2Cl2 (0.2 mL). The reaction mixture was stirred at
room temperature for 19 h. The resultant cloudy solution was diluted with Et2O (10 mL),
washed with 10% w/v aq. Na2S2O3 (10 mL), NaHCO3 saturated solution, and brine, and
dried over MgSO4. After filtration and concentration, the residual oil was purified by flash
column chromatography eluting with hexane-ether 85:15 to afford compound 4 (146 mg,
78%) as colorless oil.
Biological data
Assays were performed in 96-well polystyrene microtiter flat bottom microplates (Maxisorp,
Labclinics, Barcelona, Spain) at 32 °C using a 0.4 mM solution of p-nitrophenyl acetate
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(PNPA) in acetonitrile as substrate. Stock solutions of the possible inhibitors were prepared
in ethanol from which 2 μL were used. For the assays, 50 μL of the enzyme in sodium
phosphate buffer (containing 10 μg of hCE1) with the inhibitor was incubated for 15 min,
and then 10 μL of the substrate solution was added for a final concentration of 0.4 mM.
Each solution was diluted with sodium phosphate buffer (pH 7.8, 100 mM) to a final volume
of 200 μL. The rate of PNPA hydrolysis was monitored every 30 s for 5 min in a
Spectramax Plus plate reader (Molecular Devices, Sunnyvale, CA) at 405 nm (p-nitrophenyl
alcohol absorption). Each inhibitor concentration was tested in triplicate, and the assay was
repeated three times along with positive (in the presence of enzyme but no inhibitor) and
negative (no enzyme, no inhibitor) controls. Inhibitor concentrations were adjusted so that
the linear region of the curve had at least four points above and below the IC50. The IC50
values were determined by regression analysis of at least eight points in the linear region of
the curve. For the specific case of compounds 14–18, the experimental procedure described
by Nishi et al. was adopted [36].
Quantum mechanical computations
Theoretical calculations were performed for model compounds built up by replacing the
alkyl chain of TFMKs by an ethyl group (Fig. 1) in order to explore the reactivity properties
of the carbonyl moiety present in TFMKs. This choice is justified not only by the reduction
in cost of the quantum mechanical computations, but also to establish the relationship
between the reactive properties of the substituted ketone moiety and the inhibitory activity.
The geometries of model compounds were fully optimized at the B3LYP/6-31G(d) level
[37,38]. The nature of the stationary points was verified by inspection of the vibrational
frequencies, which were used to calculate zero point, thermal and entropic corrections
within the framework of the harmonic oscillator-rigid rotor at 1 atm and 298 K. These
corrections were added to the electronic energies to estimate the free energy differences
(ΔGgas) in the gas phase.
The relative stabilities in solution were estimated by combining the free energy difference in
the gas phase and the differences in solvation free energy (ΔGsol) determined by using the
IEF/MST solvation model [39,40], which relies on the integral equation formalism (IEF) of
the polarizable continuum method [41,42]. The IEF-MST model computes ΔGsol from the
addition of electrostatic (ΔGele), cavitation (ΔGcav) and van der Waals (ΔGvW) components.
ΔGele is determined from the interaction between the charge distribution of the solute and
the electrostatic response of the solvent, which is treated by a set of point charges spread
over the surface of the cavity that separates solute and solvent. ΔGcav is computed following
Claverie-Pierotti’s scaled particle theory [43,44]. Finally, ΔGvW is computed using a linear
relationship to the solvent-exposed surface of each atom [40,45].
IEF/MST computations were performed using the B3LYP/6-31G(d) optimized version of
the MST(IEF) model [40]. Gas phase calculations were carried out using Gaussian-03 [46],
and IEF/MST calculations were performed using a locally modified version of this program.
Molecular modeling
Docking calculations were used in conjunction with molecular dynamics simulations in
order to examine the alignment of the alkyl chain along the gorge and its effect on the
activity of selected TFMK inhibitors. To this end, the X-ray crystallographic structures of
hCE1 complexed with palmitic acid (PDB entry 2DQY; solved at 3.0 Å resolution [47]) and
benzoic acid (PDB entry 1YAJ; solved at 3.2 Å resolution [48]) were used in the docking
study. The former was chosen due to the fact that the alkyl chain of palmitic acid delineates
the gorge leading to the active site, whereas the latter was selected because the benzoic acid
is found forming a covalently-bound tetrahedral intermediate with the catalytic serine
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Ser221 in subunits C, F and J (in the rest of subunits the benzoic acid is unbound in the
catalytic site). Accordingly, these structures provide valuable information for the proper
positioning of the covalent adduct formed by the TFMK derivatives investigated here with
the hCE1 enzyme.
Docking studies were carried out using Gold 4.1 (CCDC, Cambridge) and the Goldscore
scoring function [49–51]. The X-ray structure of hCE1 was used as a template for docking
calculations after removal of ligands, ions and water molecules. The definition of the
binding site to be considered for docking of TFMK inhibitors was made taking advantage of
the known spatial arrangement of both palmitic acid and benzoic acid in the X-ray structures
2DQY and 1YAJ. The structure of each inhibitor was initially built up with the alkyl chain
in an extended conformation using MOE (Chemical Computing Group, Montreal), and the
geometry was subsequently refined by energy minimization using the MMFF94s [52] force
field. This extended conformation seemed adequate as starting geometry, as the alkyl chain
of palmitic acid is rather elongated in the complex with hCE1 (the distance from the carbon
bearing the carboxyl group to the last methylene in the conformation found in 2DQY is 11.6
Å, which compares with a value of 16.4 Å for the same distance in a fully extended
conformation). It is worth noting, however, that whereas the protein was kept rigid, Gold
accounts for the conformational flexibility of the ligand around rotatable bonds during
docking calculations. In order to explore the alignment of the inhibitor in a suitable
orientation that mimics the covalently-bound tetrahedral intermediate arising from the
nucleophilic attack of the hydroxyl group of Ser221 to the carbonyl unit of the TFMK
inhibitor, a covalent bond was imposed between the oxygen atom of Ser221 and the
carbonyl carbon atom in the inhibitor. In addition, a hydrogen bonding constraint was
imposed to bias the orientation of the carbonyl oxygen in the tetrahedral intermediate toward
the backbone NH units of Gly142 and Gly143. Thus, this constraint should account for the
stabilization played by those residues upon formation of the tetrahedral adduct in the
enzyme-substrate complex. Overall, the application of these constraints permits to enhance
the conformational search in sampling the alignment of the alkyl chain in the binding site.
Refinement of the docked complexes was accomplished by means of molecular dynamics
simulations using the parmm99 force field of the Amber-9 package [53]. The general Amber
force field (gaff; [54,55]) was used to assign parameters for the covalently-bound adduct
formed between the ketone moiety of the TFMK inhibitor and the hydroxyl group of Ser221.
In order to refine the gaff parameters, the adduct was modeled by replacing the alkyl chain
by an ethyl group and by adding acetyl and methyl groups to the N- and C-terminals of
Ser221. The geometry of this model compound was subsequently optimized at the HF/
6-31G(d) level, though the torsional angles of the backbone were kept frozen in order to
avoid an unrealistic rearrangement in the molecular geometry of the peptide units. The
optimized geometrical parameters were then used to refine the bond lengths and angles of
the tetrahedral intermediate. Moreover, in order to improve the description of the charge
distribution of the (Ser)-O-C(O)-(TFMK) unit and to describe more accurately the
hydrogen-bonding stabilization arising from the interaction with the NH units of Gly142 and
Gly143, the partial atomic charges were slightly adjusted from the RESP charges [56]
determined at the HF-6-31G(d) level (note that this level of theory was already adopted in
the derivation of the gaff force field).
The standard ionization state at neutral pH was taken for all the ionizable residues of the
enzyme but His468, which was protonated. The complexes were then immersed in a pre-
equilibrated box (ca. 1093Å3) containing the inhibitor-enzyme complex and around 17000
TIP3P [57] water molecules. Six Na+ ions were added using the CMIP strategy to neutralize
the system [58], which was then energy minimized and equilibrated using a multistep
protocol. First, the location of hydrogen atoms was energy minimized for 2000 steps of
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steepest descent. Next, the positions of water molecules and ions were relaxed for 2000
steps of steepest descent plus 5000 steps of conjugate gradient. Finally, the whole simulated
system was refined via energy minimization by combining 2000 steps of steepest descent
plus 8000 steps of conjugate gradient. At this point, the system was thermalized at 298 K by
running four 25 ps molecular dynamics simulations where the temperature was increased
from 100 to 150, 200, 250 and 298 K, respectively. Subsequently, a 10 ns MD simulation
was carried out. The system was simulated in the NPT ensemble using periodic boundary
conditions and Ewald sums for treating long-range electrostatic interactions (with the default
Amber-9 parameters). The structural analysis was performed using in house software and
standard codes (PTRAJ module) of Amber-9.
Results and discussion
TFMK inhibitors
Two series of compounds were considered to investigate the relationship between the
structure and the inhibitory potency of TFMKs. The first series includes 13 inhibitors that
combine a short alkyl chain with a ketone moiety, which is the main source of chemical
diversity due to factors such as the presence or absence of fluorine atoms in the terminal
methyl group and chemical modifications in positions vicinal to the carbonyl group
(compounds 1–13; Fig. 1). In contrast, the second series includes inhibitors that share the
same trifluoromethyl ketone moiety, but differ in the nature of the long alkyl chain
(compounds 14–17; Fig. 2). In the former case, it is reasonable to expect that the high
flexibility of the short chain should not impede the proper alignment of the inhibitor in the
catalytic site. Accordingly, the differences in inhibitory activity should mainly arise from the
intrinsic reactivity of the ketone moiety, which in turn should influence the formation of the
tetrahedral adduct with the catalytic serine. In the second case, the inhibitory potencies are
expected to reflect differences in the proper arrangement of the long alkyl chain, particularly
due to the presence of the double bond in positions β and γ (relative to the carbonyl group)
in compounds 15 and 16, respectively, compared to the activity of 14.
Reactivity studies
The efficiency of TFMKs as inhibitors of CEs is related to the susceptibility of the ketone
moiety to participate in the nucleophilic attack by the catalytic serine in the enzyme active
site, thus leading to a tetrahedral adduct that mimics the transition state of the enzyme-
substrate complex. Accordingly, in the absence of other factors that might prevent a correct
positioning of the ketone moiety in the catalytic site, those inhibitors that favor the
formation of the tetrahedral intermediate should a priori exhibit the largest biological effect.
Under this rationale, we have examined the equilibrium between keto and hydrate species of
model compounds 1–13 to gain insight into the reactivity properties of the ketone moiety.
To this end, we have adopted the thermodynamic cycle shown in Fig. 3, which allows us to
combine the intrinsic (gas phase) stability of the keto and hydrate species with the hydration
preferences of the two species. For those compounds able to form an intramolecular
hydrogen bond, a limited conformational search was also performed both in the gas phase
and in aqueous solution in order to examine the relative stability of conformers with and
without intramolecular hydrogen bonds in both phases.
The stability of the hydrate form in the gas phase (ΔGgas; Table 1) depends on the number
of fluorine atoms positioned α to the carbonyl group. Thus, the structure with the lowest
stability of the hydrate species corresponds to the non-fluorinated ketone 9 and introduction
of three fluorine atoms in the terminal methyl group (5) stabilizes the hydrate form by 8.3
kcal mol−1. This effect is also observed in the comparison of the relative stabilities for pairs
of compounds 1 and 11, 3 and 12, and 4 and 13, where fluorination largely stabilizes the
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hydrate form compared to the keto species. Similarly, formation of an intramolecular
hydrogen bond between one of the hydroxyl groups of the hydrate and the heteroatom in β
position to the carbonyl group also enhances the stability of the hydrate, as noted in the
comparison of thioether (1), sulfoxide (2), sulfone (3) or ether (4) derivatives with the
unmodified compound 5. The stability of the hydrate species is, nevertheless, reduced by
around 2–5 kcal mol−1 (ΔGsol; Table 1) upon solvation in aqueous solution. This effect can
be attributed to the weakening of the intramolecular hydrogen bond upon solvation in water.
In contrast, the relative stability of the keto and hydrate forms is less affected for those
compounds whose molecular structure does not permit the formation of such intramolecular
hydrogen bond (compounds 5, 8, 9 and 10).
The preceding discussion points out that the balance between the hydrate and keto species
depends on a subtle balance of different factors depending on the chemical nature of the
groups introduced in the ketone moiety. The degree of fluorination of the methyl group
vicinal to the carbonyl unit influences the electron density on the carbonyl carbon, which
becomes more susceptible to the nucleophilic attack of a water molecule as the number of
fluorine atoms increases. In the gas phase the stability of the hydrate form is also enhanced
by the formation of an intramolecular hydrogen bond with a neighboring group suitably
placed in the ketone moiety to act as hydrogen-bond acceptor. The magnitude of this latter
effect can however be largely counterbalanced upon solvation in polar solvents due to the
competing interactions with polar solvent molecules. The combined effect of these factors is
reflected in a sizable difference in the preference between keto and hydrate species for the
series of compounds considered in this study, as can be seen in Table 1.
It is well known that the hydration constant of carbonyl compounds in aqueous solution can
vary in a wide range (10−6 to 103) [59]. The accurate determination of the ratio between
keto and hydrate forms is difficult since the rate of hydration is usually too fast to allow
determination of the equilibrium constant by isolating one of the forms. Moreover, in many
cases the amount of keto or hydrate forms may be very small, only detectable by very
sensitive spectroscopic methods. On the basis of these considerations, we attempted to
measure experimentally the ratio between keto and hydrate forms for few selected
compounds using 19F NMR in chloroform solution (note that these assays were performed
for compounds with R= hexyl). Under these conditions, the results indicate that hydration of
the keto form follows the order sulfone (3; 100% hydrate)≥sulfoxide (2; 90–96%
hydrate)>ether (4; 78–80% hydrate)>thioether (1; 30–50% hydrate)>unsubstituted TFMK
(5; 0% hydrate) difluoromethyl ketone (8; 0% hydrate). Keeping in mind the different
polarity of the solvent used in computations (Table 1) and in experimental measurements,
one can conclude that there is satisfactory qualitative agreement between the theoretically
predicted and experimentally determined preferences between the keto and hydrate forms of
the studied compounds.
In order to rationalize the hydration extent of compounds 1–13, the free energy difference
between keto and hydrate species was compared with the partial charge of the carbonyl
carbon, which was determined by using the atoms-in-molecules theory [60]. Figure 4 shows
that there is a correlation between the free energy difference determined in aqueous solution
and the charge of the carbonyl carbon (the only exception to this behavior is compound 6,
which likely reflects the influence of the vicinal carbonyl group). Clearly, this trend can be
realized from the influence exerted by the degree of fluorination in α position and the
substitution by electron-withdrawing groups at β position of the carbonyl group on the
carbon charge, which becomes more electrophilic and therefore more prone to hydration.
The inhibitory potency determined experimentally for the TFMK inhibitors that incorporate
the ketone moieties 1–13 is given in Table 2. In general, there is a close similarity between
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the experimental activities for the two series of compounds reported in Table 2, which differ
in the length of the short alkyl chain (R is hexyl in this work, and butyl in ref. [28]). Such an
agreement supports the assumption that the differences in inhibitory potency are mainly due
to the intrinsic reactivity properties of the ketone moiety of TFMKs.
Previous studies have examined the dependence on the inhibitory potency of TFMKs and
the relative stability between ketone and hydrate species [28]. For a small series of six
compounds, which includes sulfide (1, 11), sulfone (3, 12) and ether (4, 13) methyl ketone
moieties and their trifluorinated derivatives, a linear dependence was found between the
inhibitory activity against human carboxylesterase (from human liver microsomes) and the
gas phase electronic energy difference between ketone and hydrate species [28]. Similar
linear dependencies were also found with the gas phase free energy difference and with the
relative stability estimated in aqueous solution using two solvation models [28]. These
findings mainly reflect the activating effect due to the fluorination of the terminal methyl
group in the ketone. Nevertheless, the linear dependence between the inhibitory activity and
the energetic difference of keto and hydrate species is counterintuitive, as it would a priori
suggest an enhancement in the inhibitory potency as the stability of the hydrate form is
enlarged. In fact, the kinetic study reported for the trifluorinated sulfoxide derivative 2,
whose predicted activity (pIC50=10.00) was much larger than the experimental value (pIC50
=6.51), suggested that the dehydration of the gem-diol form was likely the rate-limiting step
of binding to the enzyme.
In contrast to the preceding findings, comparison of the inhibitory potencies determined
experimentally for compounds 1–13 with the free energy difference reported here for keto
and hydrate species in aqueous solution reveals the existence of a parabolic dependence of
the IC50 values (Fig. 5). Compared to the theoretical linear relationships reported in [28], the
distinct functional dependence found in this study can be attributed to the inclusion of a
larger, more diverse set of compounds. The parabolic relationship between inhibitory
potencies and keto-hydrate relative stabilities can be understood from the balance between
two opposite factors: the hydration of the keto species and its intrinsic reactivity against a
serine residue of the enzyme. Thus, an increase in the electrophilicity of the carbonyl carbon
should enhance the reactivity for the attack of the catalytic serine residue, but at the same
time it also implies a displacement of the compound toward the hydrate form in aqueous
solution. Accordingly, the activity of those ketone moieties poorly activated for a
nucleophilic attack will be limited by the intrinsic reactivity, though they will tend to
populate the keto species in solution. Likewise, those compounds containing a ketone
moiety with enhanced reactivity toward a nucleophile will be moderate or even poor
inhibitors because the concentration of the inhibitor will mainly populate the hydrate
species, and the inhibitory activity will therefore be largely determined by the dehydration
of the gem-diol form to generate the ketone species.
Overall, Fig. 5 allows us to reconcile the predictions made from theoretical calculations for
the balance between keto and hydrate species of TFMK compounds with the experimental
evidences reported in [28], which support the crucial role played by the degree of ketone
hydration on the inhibitory potencies. Moreover, it can also be deduced that if the keto-
hydrate conversion is sufficiently dynamic as to ensure the equilibrium between those
species, increased incubation times would then result in enhanced inhibitory potencies,
because dehydration of the gem-diol species would yield the ketone species, as found in
previous experimental studies [12].
Modeling studies
The preceding results reflect the influence of the electronic properties exerted by
substituents on the reactivity of the ketone moiety. In particular, the results point out the
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important role due to fluorination in enhancing the reactivity of the compounds relative to
their non-fluorinated partners. This trend would suffice to justify the drastic reduction in the
hCE1 inhibitory activity measured for compound 18 relative to TFMKs 14 and 17 (see Fig.
2 and Table 3). Such a reduction cannot be attributed to the different length of the alkyl
chains (C18H35 in 14, and C16H31 in 17 and 18), since the terminal part of the long alkyl
chain should be easily accommodated in the mouth of the gorge, as noted upon inspection of
the different orientations found for the terminal part of the chain of palmitic acid
(C15H31COOH) in the three subunits of the X-ray crystallographic structure (PDB entry
2DQY; Fig. 6). Rather, the enhanced inhibitory potency of compounds 14 (IC50=14 nM) and
17 (IC50=9.9 nM) compared to 18 (IC50>1000 nM) can be explained by the enhanced
reactivity of TFMK associated with the presence of fluorine atoms in α position to the
carbonyl.
Surprisingly, the data in Table 3 also shows a drastic reduction in the inhibitory potency of
compound 15 (IC50>1000 nM), which compares with the similar change in activity observed
for the non-fluorinated compound 18. This unexpected trend cannot be realized from
electronic factors, as the trifluorinated methyl ketone moiety is preserved in compound 15,
which should therefore have similar propensities for the nucleophilic attack by the catalytic
Ser221. Likewise, the weak inhibitory activity of 15 can hardly be attributed to the
hydrophobicity of the compound, as the length of the alkyl chain is identical in compounds
14–16, which only differ in the number and location of the double bonds present in the
chain. Inspection of the chemical structures of those compounds suggests that the poor
inhibitory potency of 15 could be attributed to the precise location of the double bond
between β and γ positions in the alkyl chain, as the inhibitory activity of compound 16 (IC50
=11.8 nM), where such a double bond involves carbon atoms γ and δ, nearly matches the
activity of 14 and 17. Therefore, it can be hypothesized that the conformational restraints
imposed by the double bond could affect the proper alignment of the TFMK inhibitor in the
catalytic site, thus preventing the formation of the tetrahedral intermediate with the catalytic
serine residue.
To corroborate this hypothesis, docking calculations were combined with molecular
dynamics simulations in order to examine the ability of the catalytic site to accommodate the
covalently bound adducts generated from inhibitors 14–16. Inspection of the docked poses
revealed that the alkyl chain was generally suitably aligned along the hydrophobic gorge.
However, due to the pharmacophore constraints imposed to the carbonyl group of the ketone
in docking computations (see Methods), two main orientations were found for the terminal
trifluorinated methyl group, as noted in Fig. 7 for compound 14 (similar results were
obtained for 15 and 16; data not shown). In the two poses the orientation of the
trifluoromethyl ketone moiety permits the correct positioning of the hydroxyl oxygen of
Ser221 for the nucleophilic attack to the carbonyl carbon. Moreover, the hydroxyl unit in
Ser221 is assisted by a hydrogen bond with the imidazole ring of His468. Nevertheless, the
two poses differ in the orientation of the trifluoromethyl unit in the binding site. In one case
(shown in orange in Fig. 7) no steric clash is observed between the trifluoromethyl group
and the neighboring residues in the catalytic site. However, in the other case (shown in
yellow in Fig. 7) the trifluorinated methyl is positioned close to the NH unit of Gly142 and
the imidazole ring of His468, suggesting the existence of unfavorable clashes. Accordingly,
this latter pose was not considered for further analysis in molecular dynamics simulations.
The structural integrity of the most favored pose for the tetrahedral adduct formed between
inhibitors 14–16 and the catalytic serine of hCE1 was examined by means of 10 ns
molecular dynamics simulations. Inspection of the time evolution of the potential energy of
the simulated systems supported the stability of the trajectories in the last 5 ns (see Fig. S1
in Supporting Information). The profile for the positional root-mean square deviation
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(RMSD) of the backbone atoms ranged from 1.8 to 2.0 Å and remained stable during the last
3 ns, thus reflecting a small relaxation of the overall protein skeleton compared to the X-ray
crystallographic structure (see Fig. S1). The RMSD of the heavy atoms for the residues that
delineate the walls of the catalytic site and the gorge was smaller (ranging from 1.3 to 1.8 Å)
and remained stable along the last 4 ns of the trajectories (Fig. 8).
Though the preceding results point out that the overall stability of the trajectories was
similar for the three hCE1-inhibitor complexes, careful inspection of the residues at the
binding site reveals a significant difference in the conformation of His468. This residue
plays a relevant functional role, as it contributes to enhance the nucleophilicity of Ser221
through the formation of a hydrogen bond, and in turn interacts with Glu354. Thus,
inspection of the three subunits present in the X-ray crystallographic structure 2DQY
indicates that the distances from O (Ser221) to Nε(His468) vary between 2.9 and 3.2 Å, and
the distances from Nδ(His468) to O(Glu354) range from 2.6 to 2.8 Å. Interestingly, the triad
formed by Ser221, His468, and Glu354 is structurally stable along the trajectories run for
the adducts generated from TFMKs 14 and 16 (see Fig. 9). Thus, the hydrogen bond
between Ser221 and His468 remains stable along the whole trajectory (with an average
distance close to 2.9 Å; see Fig. 10). In contrast, the structural arrangement of the catalytic
triad is completely lost in the simulation run for inhibitor 15 (Fig. 9), as noted in the large
interatomic distance between O(Ser221) and Nε(His468) (> 6 Å; Fig. 10).
The structural alteration of the catalytic triad, which is found since the beginning of the
production run, would imply the loss of the catalytic power. Accordingly, such structural
alteration should reduce the nucleophilicity of the serine residue, thus limiting the efficiency
of the chemical process leading to the formation of the tetrahedral intermediate between
enzyme and inhibitor. Ultimately, this drastic structural change reflects the steric clash that
arises between the side chain of His468 and the restricted conformation of the alkyl chain
imposed by the presence of the double bond between positions β and γ for compound 15,
which is nevertheless completely alleviated in 16.
Even though compounds 14–16 can be viewed as very close analogues sharing similar
intrinsic reactivity properties in the ketone moiety, the positional isomerism of the double
bond has a dramatic impact on the inhibitory potency. According to present results, the
apparently minor structural change associated with the presence of the double bond in
position β or γ is crucial, as it triggers a profound structural alteration in the catalytic triad
upon formation of the tetrahedral intermediate with 15, while the adduct is properly
accommodated upon positional isomerism of the double bond to position γ in 16.
Final remarks
Previous studies have indicated that an increased hydrophobicity correlates with inhibitor
potency, so that compounds containing longer, more hydrophobic alkyl chains are more
potent inhibitors of CEs [12,27]. Clearly, this trend reflects the lipophilic nature of the
gorge, as found in the X-ray crystallographic structure of hCE1, where the binding site is
lined by residues such as Ala93, Leu97, Val146, Val254, Leu255, Leu299, Phe303, Leu304,
Ile359, Leu363, and Met425. However, other factors are expected to play a decisive role on
the inhibitory activity of TFMKs.
The results reported here allow us to stress the relevant role played by substituents present in
the ketone moiety, which modulate the intrinsic reactivity against a nucleophilic attack, but
also the balance between keto and hydrate species. Thus, the parabolic dependence found
between the inhibitory potency and the relative stability between keto and hydrate forms of
TFMKs strongly support the hypothesis that the inhibitory potency is related to the degree of
ketone hydration, as noted in previous studies [28]. Such dependence suggests a direct
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implication of the electrophilicity of the carbonyl carbon atom of the ketone moiety in two
counterbalancing effects: the susceptibility for the nucleophilic attack of the catalytic serine
residue of the enzyme, and the degree of hydration of the ketone species.
In this context, present findings support the assumption of the keto species as the bioactive
form of TFMK inhibitors [61] provided that the TFMK could fit properly in the catalytic
cavity. The presence of apparently minor chemical modifications in positions close to the
ketone moiety may thus have an unexpected effect on the inhibitory potency. This is the
case of the positional isomerism associated with the displacement of the double bond from β
to γ position in compounds 15 and 16, which gives rise to a drastic change in the inhibitory
activity. In this case, the intrinsic reactivity properties of the trifluorinated methyl ketone
moiety are overridden by the steric factors associated with accommodation of the inhibitor.
In turn, these findings pave the way to take advantage of structural differences in the binding
site in order to modulate the selectivity of this class of compounds toward different CEs.
Understanding the molecular determinants that modulate the interaction of TFMK inhibitors
with CEs is necessary in order to develop compounds with improved pharmacological and
agricultural properties. Based on the preceding findings and their implication for the
mechanism of action of TFMKs, we feel that selectivity of inhibitors with a central
pharmacophore of a polarized ketone for different target enzymes can be modulated through
the inclusion of suitable substituents in the chemical structure that contains the ketone
moiety. Finally, it is likely that general conclusions drawn from the interaction of TFMK
inhibitors and CEs can be extended to the design of inhibitors of other targets such as fatty
acid amide hydrolase [15] and diacyl glycerol [16].
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
Representation of selected ketone moieties in a series of TFMK inhibitors bearing a short
alkyl chain (R is hydrogen in the model compounds used in quantum mechanical
computations)
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Fig. 2.
Representation of selected TFMK inhibitors containing a trifluoromethyl ketone moiety or
its unsubstituted partner, but differing in the nature of the long alkyl chain
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Fig. 3.
Thermodynamic cycle used to explore the relative stability of keto and hydrate species of
ketone moieties 1–13 in aqueous solution
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Fig. 4.
Representation of the free energy difference in aqueous solution between keto and hydrate
forms and the charge of the carbonyl carbon for compounds 1–13
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Fig. 5.
Comparison of the experimental IC50 values with the free energy difference between keto
and hydrate species in aqueous solution
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Fig. 6.
Detailed view of the orientations adopted by the alkyl chain of palmitic acid (in orange) in
the three subunits of the complex with hCE1 (PDB entry 2DQY). The catalytic serine
residue is shown in colored spheres
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Fig. 7.
Detailed view of the two main poses found in docking computations of compound 14. The
plot also shows the catalytic residue His468, and the residues Gly142 and Gly143, which
stabilize via hydrogen bonding the tetrahedral intermediate. In the yellow pose the
trifluoromethyl group makes unfavorable contacts with the NH unit of Gly142 and the
imidazole ring of His468. In the orange pose, however, no steric clash is observed between
the trifluoromethyl group and the neighboring residues in the catalytic site
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Fig. 8.
Time evolution of the positional root-mean square deviation (Å) of the heavy atoms that
delineate the catalytic site and the gorge along the 10 ns trajectories sampled for the hCE1
complexes with inhibitors 14 (black), 15 (green) and 16 (red)
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Fig. 9.
Detailed view of the tetrahedral adduct formed between the trifluorinated methyl ketone
moiety of inhibitors 14 (top), 15 (middle), and 16 (bottom) with the catalytic serine Ser221
at the end of the 10 ns trajectories. The plots also show the catalytic residues His468 and
Glu354, as well as residues Gly142 and Gly143
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Fig. 10.
Time evolution of the hydrogen-bond distance (Å) between the oxygen atom of Ser221 and
the imidazole nitrogen (Nε) of His468 along the 10 ns trajectories sampled for the hCE1
complexes with inhibitors 14 (black), 15 (green) and 16 (red)
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Table 1
Free energy differences (kcal mol−1) for the formation of the hydrate species in the gas phase (ΔGgas) and in
aqueous solution (ΔGsol) for model compounds 1–13
Compound ΔGgas ΔGsol Hydrate form (%)
1 −3.5 0.2 98
2 −3.2 −0.2 99
3 −3.6 −1.4 100
4 −4.0 −0.5 99
5 1.6 3.3 18
6 −6.2 −2.8 100
7 −3.1 −0.4 99
8 4.5 4.7 2
9 9.9 10.5 0
10 2.0 2.5 44
11 4.3 9.4 0
12 2.9 6.3 0
13 1.6 6.5 0
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Table 2
Experimental data for the inhibitory potencya of TFMK compounds 1–13
Compound − log IC50 (± SE) b − log IC50 (± SE) c
1 7.9 (0.04) 8.1
2 7.4 (0.04) 6.5
3 7.3 (0.04) 7.3
4 7.7 (0.02) 7.3
5 7.6 (0.06) —
6 5.9 (0.05) —
7 6.1 (0.03) —
8 6.5 (0.05) —
9 <3 —
10 7.2 (0.1) —
11 — 4.6
12 — 4.0
13 — 4.3
a
IC50 is the inhibitor concentration (M) that reduces the esterase activity by 50%. SE: standard error
b
This work; R=hexyl
c
R=butyl; taken from ref. [28]
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Table 3
Experimental data for the inhibitory potency (IC50; nM)a of TFMK compounds 14–18
Compound IC50 (± SE)
14 14.0±2.0
15 >1000
16 11.8±0.7
17 9.9±0.9
18 >1000
a
IC50 is the inhibitor concentration (M) that reduces the esterase activity by 50%. SE: standard error
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